BIO-key International
BKYI
8 hedge funds and large institutions have $69.8K invested in BIO-key International in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
1.47% less ownership
Funds ownership: 1.61% → 0.15% (-1.5%)
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
83% less capital invested
Capital invested by funds: $399K → $69.8K (-$329K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$10.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.76K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$2.95K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$348K |
| 2 |
VF
Virtu Financial
New York
|
-$12K |
| 3 |
Citigroup
New York
|
-$338 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$206 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2 |
BKYI Hedge Fund Activity: Q2 2025 in Review
8 of the 7,609 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2025, worth a combined $69.8K — down 83% from $399K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BKYI and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, opening a new position worth an estimated $11.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $348K sold.
- 8 institutional investors held BIO-key International (BKYI) as of Q2 2025, down from 10 in Q1 2025.
- Funds reported $69.8K of BIO-key International stock for Q2 2025, down 83% quarter-over-quarter.
- 2 funds opened new BIO-key International positions in Q2 2025 and 4 closed out, a net change of -2 holders.
- The largest BIO-key International buyer in Q2 2025 was UBS Group, an estimated $11.2K added.
- The largest BIO-key International seller in Q2 2025 was Armistice Capital, an estimated $348K sold.
Based on aggregated 13F filings for Q2 2025.